Board meeting on November 5 to consider and approve Q2 and H1 results
Board meeting scheduled for Thursday, November 5, 2026.
By ScoutQuest · · 1 min read
- Board Meeting Date
- Thursday, November 5, 2026
- Agenda
- Un-Audited Standalone and Consolidated financial results for the quarter and half year ended September 30, 2026
- Trading Window
- closed from October 1, 2026; stays closed until 48 hours after the results are announced
What the notice says
The company has written to both BSE (Scrip Code 544578) and NSE (Symbol RUBICON) to say that a meeting of its Board of Directors is scheduled for Thursday, November 5, 2026. The notice is an intimation of a board meeting, not the results themselves.
What the board will consider
- The Un-Audited Standalone and Consolidated financial results of the company.
- The period covered is the quarter and half year ended September 30, 2026.
The word used in the update is that the board will "consider and approve" these results, so the numbers are not yet public.
Trading window
- The trading window for dealing in the company's shares has been closed with effect from October 1, 2026.
- It shall remain closed until 48 hours after the announcement of the Un-Audited Financial Results for the quarter and half year ended September 30, 2026.
This is a standard internal restriction that applies to designated persons under the company's Code of Conduct for Prevention of Insider Trading. It is not a restriction on the company's shares in general.
How to read this
- This is a calendar notice: it tells investors the date on which the September quarter numbers will be taken up by the board.
- The actual financial performance, revenue, margins and profit for the quarter and half year are not part of this intimation.
- Until the board approves and the results are announced, the trading window remains shut for those covered by the code.
What to watch
The Standalone and Consolidated results for the quarter and half year ended September 30, 2026, once approved and announced after the November 5, 2026 meeting.
Also from Rubicon Research
USFDA issues Form 483 with 5 procedural observations after Ambernath plant inspection
30 Oct 2026
Earnings conference call scheduled for November 5 to discuss Q2 and H1 FY27 performance
28 Oct 2026
US FDA issues Form 483 with 1 observation after unannounced inspection of Satara plant
9 Oct 2026
More numbers
- Gap after results announcement before trading window reopens48 hours
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.